Food and Drug Administration (FDA) - "Saxenda (Liraglutide) Injection, for Subcutaneous Use." Accessed on April 3, 2024, at FDA - "Drug Compounding and Drug Shortages." Accessed on April 3, 2024, at Harvard T.H
Usually scalp or butt
Formerly FDA-approved as Geref
This includes reviewing your thyroid function tests, ensuring your levothyroxine dose is optimised, and discussing any risk factors such as family history of MTC or MEN 2
Protect from excessive heat, freezing environments, and direct light exposure to maintain peptide stability
We also offer telehealth consultations for the initial intake and follow-up appointments so patients outside the immediate Summerlin area can still access our peptide programs with minimal in-person visits required